Managing acne in the managed care environment

D. P. West*, N. H. Han

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review


The medical community is currently faced with the challenge of determining how best to incorporate seven new antiacne products into existing formularies and treatment paradigms. These new products include two new tretinoin reformulations designed to keep the active ingredient predominantly in the upper layers of the skin; two new-generation retinoids that were designed to be less irritating than tretinoin; a new sulfacetamide product formulated without sulfur or alcohol; a novel azelaic acid cream; and an oral contraceptive that has recently been approved for the treatment of acne. This review provides a brief overview of current approaches to treatment followed by an evaluation of the potential roles of each new product in evolving disease-management strategies. Information on the dosing, efficacy, safety, mechanism of action, pricing, and other distinguishing characteristics of each product have been tabulated to facilitate comparison.

Original languageEnglish (US)
Pages (from-to)119-122+125
JournalP and T
Issue number3
StatePublished - 1999

ASJC Scopus subject areas

  • Pharmacology (medical)


Dive into the research topics of 'Managing acne in the managed care environment'. Together they form a unique fingerprint.

Cite this